Explore

Trendline Trendline
Nika Pharmaceuticals Reports First-Quarter 2026 Financial Results Indicating Continued Net Loss

Nika Pharmaceuticals Reports First-Quarter 2026 Financial Results Indicating Continued Net Loss

Nika Pharmaceuticals Reports First-Quarter 2026 Financial Results Indicating Continued Net Loss
Trendline Trendline
Anteris Technologies Reports Q1 2026 Financial Results with Increased Net Loss

Anteris Technologies Reports Q1 2026 Financial Results with Increased Net Loss

Anteris Technologies Reports Q1 2026 Financial Results with Increased Net Loss
Trendline Trendline
TherapeuticsMD Reports First Quarter 2026 Financial Results

TherapeuticsMD Reports First Quarter 2026 Financial Results

TherapeuticsMD Reports First Quarter 2026 Financial Results
Trendline Trendline
Natura Reports Q1 2026 Financial Struggles Amid Brazilian and Argentine Market Pressures

Natura Reports Q1 2026 Financial Struggles Amid Brazilian and Argentine Market Pressures

Natura Reports Q1 2026 Financial Struggles Amid Brazilian and Argentine Market Pressures
Trendline Trendline
JD Sports Reports 2026 Financial Results with Mixed Sales Performance Across Regions

JD Sports Reports 2026 Financial Results with Mixed Sales Performance Across Regions

JD Sports Reports 2026 Financial Results with Mixed Sales Performance Across Regions
Trendline Trendline
Koito Manufacturing Faces Profitability Challenges with Net Margin Drop to 1.7%

Koito Manufacturing Faces Profitability Challenges with Net Margin Drop to 1.7%

Koito Manufacturing Faces Profitability Challenges with Net Margin Drop to 1.7%
Trendline Trendline
Hain Celestial's Q3 2026: Debt Reduction Amid Financial Losses

Hain Celestial's Q3 2026: Debt Reduction Amid Financial Losses

Hain Celestial's Q3 2026: Debt Reduction Amid Financial Losses
Trendline Trendline
Hain Celestial Reports Debt Reduction Amid Third Quarter Losses

Hain Celestial Reports Debt Reduction Amid Third Quarter Losses

Hain Celestial Reports Debt Reduction Amid Third Quarter Losses
Trendline Trendline
Hain Celestial Reports Q3 2026 Loss Amid Debt Reduction Efforts

Hain Celestial Reports Q3 2026 Loss Amid Debt Reduction Efforts

Hain Celestial Reports Q3 2026 Loss Amid Debt Reduction Efforts
Trendline Trendline
Hain Celestial Reports Q3 2026 Financial Results with Debt Reduction

Hain Celestial Reports Q3 2026 Financial Results with Debt Reduction

Hain Celestial Reports Q3 2026 Financial Results with Debt Reduction
Trendline Trendline
Nika Pharmaceuticals Reports First-Quarter 2026 Financial Results with Net Loss

Nika Pharmaceuticals Reports First-Quarter 2026 Financial Results with Net Loss

Nika Pharmaceuticals Reports First-Quarter 2026 Financial Results with Net Loss
Trendline Trendline
CTX Reports 59% Revenue Increase Amid Widening Net Loss and Pending Acquisition

CTX Reports 59% Revenue Increase Amid Widening Net Loss and Pending Acquisition

CTX Reports 59% Revenue Increase Amid Widening Net Loss and Pending Acquisition